Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project.

By M. Sant, C. Allemani, C. Ţereanu, R. De Angelis, R. Capocaccia, O. Visser, R. Marcos-Gragera, M. Maynadié, Arianna Simonetti, J. Lutz and 1 more. Blood, 2010

917 citations recorded by the source corpus.

Subfields: Genetics, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/015a5a0bfe05c3d9696297f4c431d27595d821ce

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Alexandra G. Smith
2. D. Howell
3. Eve Roman
4. Andrew Jack
5. R. Patmore

Citations in the corpus

• Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network (2011, methodology): “…population, as well as the application of appropriate disease classifications, and it is the attainment of these two key components that continues to beleaguer epidemiological research into the haematological malignancies (National Institute for Clinical Excellence, 2003; Sant et al, 2009, 2010).”
• Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2012, neutral): “8/100 000/year [1].”